Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q2 2024 · 10-Q
Revenue$195.89M$195.89M+29.6% vs Q2 2023 Net Income$9.79M$9.79MN/M vs Q2 2023 EPS Diluted$0.32$0.32N/M vs Q2 2023 Gross Profit$166,042,000+30.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$78,000N/M Free Cash Flowderived-$12,471,000N/M Margins · derivedGross margin84.8%+0.8 pt vs Q2 2023
Operating margin2.6%+13.6 pt vs Q2 2023
Net margin5.0%+12.9 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 6, 2024 · 37 d after period end